Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Immune Checkpoint Inhibitors × Lymphoid × Clear all

Status

Sponsor Class

Study Type

Interventional 6 Observational 1

Sponsor

Cancer Type

Gastrointestinal 25 Thoracic 15 Tumor-Agnostic 2 Breast 2 Lymphoid 1 Head & Neck 1 Genitourinary 1 Dermatologic 1

Conditions

Hodgkin Disease 1

Interventions

Rituximab 23 Surveys and Questionnaires 21 Gene Expression Profiling 12 Blood Specimen Collection 12 Polymerase Chain Reaction 11 Flow Cytometry 11 Amplified Fragment Length Polymorphism Analysis 10 Observation 9 Microarray Analysis 9 Lenalidomide 9 Watchful Waiting 8 Interviews as Topic 8 obinutuzumab 7 ibrutinib 7 Immunohistochemistry 7 Cytogenetic Analysis 7 Therapeutics 6 Magnetic Resonance Spectroscopy 6 Immunologic Techniques 5 Drug Therapy 5 Data Collection 5 tisagenlecleucel 4 Vincristine 4 Psychiatric Rehabilitation 4 Prednisone 4 Inotuzumab Ozogamicin 4 In Situ Hybridization, Fluorescence 4 Gene Rearrangement 4 Daunorubicin 4 Cyclophosphamide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04419441 2020-09-16

ICI-RT-1

Ospedale Maggiore Di Trieste

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡